StudyFinder
Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years
Recruiting
This study will enroll children aged 6 to 12 years who have difficulty in maintaining a healthy weight and see if the medication Vyvanse may help them to reduce their weight.
Male or Female
Up to 18 years old
Inclusion Criteria:
• children 6 to 12 years old
• severe obesity defined as BMI greater than or equal to 1.2 times the 95th percentile
• failed attempt of lifestyle therapy
Exclusion Criteria:
• significant congenital or structural heart disease or arrhythmia
• hypertension
• history of chemical dependency
• Diabetes mellitus (type 1 or 2)
• current or recent ( less than 3 months ago) use of anti-obesity medication(s)
• additional medical or mental health conditions (study staff will review)
Children's Health, Diabetes & Endocrine
healthy weight, Obesity